Clinical Trial Update: THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension [NA]

View source ↗

Summary

An ongoing clinical trial is evaluating the THRIVE THerapeutic IntravasculaR Ultrasound Renal Denervation System (TIVUS) versus sham as an adjunctive treatment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• THRIVE THerapeutic IntravasculaR Ultrasound Renal Denervation System (TIVUS)

Snippet

Sponsor: SoniVie Inc. | Conditions: Hypertension | NA | Status: RECRUITING